Our Portfolio

With a specialized portfolio, Multicare helps provide patients with reliable access to therapies for rare and highly complex diseases.

5

Kanuma® (sebelipase alfa)

5

Soliris® (eculizumabe)

5

Strensiq® (alfa-asfotase)

5

Ultomiris® (Ravulizumabe)

5

Kuvan® (sapropterin dihydrochloride)

5

Naglazyme® (galsulfase)

5

Palynziq® (pegvaliase-pqpz)

5

Vimizim® (elosulfase alfa)

5

Voxzogo™ (vosoritide) Injection

5

Tepezza® (teprotumumabe)

5

Orfadin® (nitisinona)

5

Carbaglu® (ácido carglúmico)

5

Cystadane® (betaína)

5

Neoprofen® (Levolisinato de ibuprofeno)

5

Panhematin® (hemina)

5

Signifor® LP (pamoato de pasireotida)

5

Upelior® (diaspartato de pasireotida)

5

Kalydeco® (ivacaftor)

5

Orkambi® (lumacaftor/ivacaftor)

5

Symdeko® (tezacaftor/ivacaftor)

5

Trikafta® (elexacaftor / tezacaftor / ivacaftor + ivacaftor)

Need help finding the product you’re looking for?

Talk to our team. Our scope of services is designed to provide high-quality end-to-end support for accessing medicines.

Partner Laboratories - All brands, trademarks, and logos are the exclusive property of the producers (laboratories) and are under their copyright.